Literature DB >> 29686546

Usefulness of left ventricular mass change to predict progression of renal dysfunction in Hispanics.

Sarmad Said1, Mohamed Teleb1, Aymen Omar Albaghdadi2, Obiajulu Kanu2, Miraie Wardi2, Kyari Sumayin Ngamdu2, Lutf Rahman Sroush2, Majd Michael2, Asmik Asatrian2, Riyadh Salih Salman3, Debabrata Mukherjee1.   

Abstract

There is a strong relation between metabolic syndrome (MetS) and left ventricular (LV) mass in Hispanic patients. This population also tends to have a higher incidence of kidney disease, with progression to dialysis. We analyzed the change in LV mass in 982 Hispanic patients with MetS and used these data to anticipate the progression of renal dysfunction. Glomerular filtration rate (GFR) was calculated using the formula described by the Chronic Kidney Disease Epidemiology Collaboration. Echocardiographic data were collected using 2-dimensionally guided M-mode echocardiography measures. The data collected were then analyzed using linear regression analyses. Results showed a lower average GFR in individuals classified as having a severe change in LV mass in comparison to those with milder change in LV mass (P < 0.0001). This relation was also demonstrated when those with severe change in LV mass were compared with the control group (P < 0.0001). In those ≥54 years old, the presence of MetS and LV mass were negatively correlated with GFR (regression coefficient [RC] = 14.76, P < 0.063; RC = 0.11, P < 0.0001 respectively). In patients <54 years old, no statistically significant association between the presence of MetS and GFR was seen. However, LV mass was once again negatively correlated with GFR (RC = 0.15, P < 0.0001). In conclusion, results demonstrated the association between the MetS, change in LV mass, and chronic kidney disease progression.

Entities:  

Keywords:  Heart failure; metabolic syndrome; renal failure

Year:  2018        PMID: 29686546      PMCID: PMC5903522          DOI: 10.1080/08998280.2017.1401376

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  6 in total

Review 1.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

2.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary.

Authors:  Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus
Journal:  Crit Pathw Cardiol       Date:  2005-12

Review 3.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

4.  The metabolic syndrome and chronic kidney disease in U.S. adults.

Authors:  Jing Chen; Paul Muntner; L Lee Hamm; Daniel W Jones; Vecihi Batuman; Vivian Fonseca; Paul K Whelton; Jiang He
Journal:  Ann Intern Med       Date:  2004-02-03       Impact factor: 25.391

5.  Association between Metabolic Syndrome and Microalbuminuria in Korean Adults.

Authors:  Hyun-Ok Lee; Hyun-Ju Bak; Jin-Young Shin; Yun-Mi Song
Journal:  Korean J Fam Med       Date:  2015-03-23

6.  Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors.

Authors:  William E Moody; Charles J Ferro; Nicola C Edwards; Colin D Chue; Erica Lai Sze Lin; Robin J Taylor; Paul Cockwell; Richard P Steeds; Jonathan N Townend
Journal:  Hypertension       Date:  2016-02       Impact factor: 10.190

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.